Richard E Carson Selected Research

AS2471907

10/2021

Imaging brain cortisol regulation in PTSD with a target for 11β-hydroxysteroid dehydrogenase type 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard E Carson Research Topics

Disease

15	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 09/2003
11	Schizophrenia (Dementia Praecox) 01/2020 - 02/2004
9	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022 - 02/2005
8	Cognitive Dysfunction 01/2022 - 01/2016
7	Wounds and Injuries (Trauma) 10/2021 - 09/2011
6	Mental Disorders (Mental Disorder) 01/2022 - 08/2013
5	Parkinson Disease (Parkinson's Disease) 01/2022 - 12/2004
5	Obesity 01/2022 - 02/2014
5	Alcoholism (Alcohol Abuse) 01/2022 - 05/2010
5	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 07/2006
5	Neoplasms (Cancer) 06/2018 - 08/2003
5	Substance-Related Disorders (Drug Abuse) 03/2016 - 03/2013
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2016
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2020 - 06/2012
4	Temporal Lobe Epilepsy 10/2020 - 07/2005
4	Cocaine-Related Disorders (Cocaine Addiction) 01/2019 - 01/2010
3	Neuroinflammatory Diseases 07/2017 - 09/2008
3	Anxiety Disorders (Anxiety Disorder) 01/2017 - 03/2013
3	Inflammation (Inflammations) 10/2015 - 04/2012
3	Mood Disorders (Mood Disorder) 08/2013 - 06/2010
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 06/2012 - 11/2010
2	Dementia (Dementias) 01/2022 - 01/2020
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2022 - 11/2011
2	Stroke (Strokes) 01/2022 - 01/2019
2	Hypoxia (Hypoxemia) 01/2018 - 12/2017
2	Brain Neoplasms (Brain Tumor) 01/2016 - 07/2013
2	Bipolar Disorder (Manic Depressive Psychosis) 08/2013 - 07/2006
2	Panic Disorder (Panic Attack) 10/2008 - 01/2004
2	Atrophy 12/2007 - 07/2005
2	Memory Disorders (Memory Loss) 07/2006 - 09/2003
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2022
1	Synucleinopathies 01/2022
1	Overweight 01/2022
1	Epilepsy (Aura) 10/2020
1	Hyperglycemia 01/2020
1	Insulin Resistance 01/2020
1	Edema (Dropsy) 01/2019
1	Ischemic Stroke 01/2019
1	Infarction (Infarctions) 01/2019

Drug/Important Bio-Agent (IBA)

10	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 02/2004
9	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 01/2004
9	Glycoproteins (Glycoprotein)IBA 01/2022 - 07/2017
7	Glutamic Acid (Glutamate)FDA Link 01/2022 - 08/2013
7	Proteins (Proteins, Gene)FDA Link 10/2021 - 11/2011
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
5	Metabotropic Glutamate 5 ReceptorIBA 11/2020 - 08/2013
4	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2018
4	kappa Opioid Receptors (kappa Opioid Receptor)IBA 11/2021 - 03/2013
4	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2021 - 11/2014
4	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2020 - 01/2010
4	Pharmaceutical PreparationsIBA 03/2016 - 05/2011
3	EnzymesIBA 10/2021 - 01/2016
3	naxagolideIBA 01/2021 - 01/2020
3	Cocaine (Cocaine HCl)IBA 01/2021 - 06/2014
3	CannabinoidsIBA 12/2020 - 12/2012
3	LigandsIBA 01/2018 - 10/2012
3	Glucose (Dextrose)FDA LinkGeneric 07/2017 - 12/2007
3	Opioid Receptors (Opioid Receptor)IBA 02/2016 - 04/2013
3	Anticonvulsants (Antiepileptic Drugs)IBA 02/2016 - 03/2006
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2022 - 01/2022
2	Antidepressive Agents (Antidepressants)IBA 01/2022 - 08/2013
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2022 - 12/2011
2	Biological ProductsIBA 01/2022 - 06/2010
2	GlucocorticoidsIBA 10/2021 - 01/2017
2	1- ((3- (methylpyridin- 4- yl)methyl)- 4- (3,4,5- trifluorophenyl)pyrrolidin- 2- oneIBA 01/2021 - 12/2019
2	dihydrotetrabenazineIBA 12/2018 - 10/2018
2	fluoromisonidazoleIBA 01/2018 - 12/2017
2	gamma-Aminobutyric Acid (GABA)IBA 01/2017 - 10/2008
2	Glycine Plasma Membrane Transport ProteinsIBA 03/2016 - 12/2015
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2016 - 10/2014
2	CytokinesIBA 10/2015 - 04/2012
2	Amphetamine (Amfetamine)FDA LinkGeneric 04/2015 - 02/2004
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 10/2014 - 12/2012
2	3- (6- methylpyridin- 2- ylethynyl)cyclohex- 2- enone- O- methyloximeIBA 01/2014 - 08/2013
2	EndotoxinsIBA 10/2012 - 04/2012
2	GABA-A Receptors (GABA(A) Receptor)IBA 06/2012 - 10/2008
2	ApolipoproteinsIBA 07/2006 - 09/2003
2	Cholinergic Agents (Cholinergics)IBA 07/2006 - 09/2003
1	2- (2- (dimethylaminomethylphenylthio))- 5- fluoromethylphenylamineIBA 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022
1	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2022
1	AD 5IBA 01/2022
1	Ketamine FDA LinkGeneric 01/2022
1	GR 89696IBA 11/2021
1	AS2471907IBA 10/2021
1	Oxidoreductases (Dehydrogenase)IBA 10/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	C-Reactive ProteinIBA 12/2020
1	GSK215083IBA 01/2020
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	serotonin 6 receptorIBA 01/2020
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 01/2020
1	saracatinibIBA 12/2019
1	Betulinic AcidIBA 01/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019
1	AntioxidantsIBA 01/2019
1	Dynorphins (Dynorphin)IBA 01/2019
1	Glyburide (Glibenclamide)FDA LinkGeneric 01/2019

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2022 - 07/2013
5	Therapeutics 01/2022 - 10/2006